Genome editing technologies to treat rare liver diseases
Authors:
Open Access
- 1 April 2020
- journal article
- review article
- Published by AME Publishing Company in Translational Gastroenterology and Hepatology
- Vol. 5, 23
Abstract
Liver has a central role in protein and lipid metabolism, and diseases involving hepatocytes have often repercussions on multiple organs and systems. Hepatic disorders are frequently characterized by production of defective or non-functional proteins, and traditional gene therapy approaches have been attempted for years to restore adequate protein levels through delivery of transgenes. Recently, many different genome editing platforms have been developed aimed at correcting at DNA level the defects underlying the diseases. In this Review we discuss the latest applications of these tools applied to develop therapeutic strategies for rare liver disorders, in particular updating the literature with the most recent strategies relying on base editors technology.Keywords
This publication has 91 references indexed in Scilit:
- Inducible Arginase 1 Deficiency in Mice Leads to Hyperargininemia and Altered Amino Acid MetabolismPLOS ONE, 2013
- Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cellsNature, 2011
- In vivo genome editing restores haemostasis in a mouse model of haemophiliaNature, 2011
- Homing Endonucleases: From Microbial Genetic Invaders to Reagents for Targeted DNA ModificationStructure, 2011
- PhenylketonuriaThe Lancet, 2010
- Adeno‐associated virus gene repair corrects a mouse model of hereditary tyrosinemia in vivo†‡Hepatology, 2010
- Robust expansion of human hepatocytes in Fah−/−/Rag2−/−/Il2rg−/− miceNature Biotechnology, 2007
- Molecular Characterization of Loss-of-Function Mutations in PCSK9 and Identification of a Compound HeterozygoteThe American Journal of Human Genetics, 2006
- Sequence Variations inPCSK9,Low LDL, and Protection against Coronary Heart DiseaseNew England Journal of Medicine, 2006
- Mutations in PCSK9 cause autosomal dominant hypercholesterolemiaNature Genetics, 2003